Dr Reddy’s, RDIF start clinical preliminaries for Russia’s Sputnik V COVID-19 vaccine in India Kumar Jeetendra | December 2, 2020 Dr Reddy’s Laboratories Ltd and the Russian Direct Investment Fund (RDIF) announced on December 1 the commencement of elastic phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving mandatory clearance from the Central Drugs Laboratory, Kasauli in Himachal Pradesh. The Indian drug maker said this will be a multi-centre and randomised …
Advances in Microplate Technology at SLAS 2021 Kumar Jeetendra | December 2, 2020 Porvair Sciences will exhibit its latest specialist microplates and microplate instrumentation at the forthcoming SLAS 2021 Digital International Conference and Exhibition (January 25-27th 2021). Microplates product manager – Krzysztof Kielmann commented “A particular focus of our virtual exhibit will be specialist microplates and instrumentation for labs supporting the global COVID-19 testing effort. Many SARS-CoV-2 testing …
Researchers distinguish systems behind inflammasome initiation by fungal pathogens Kumar Jeetendra | December 3, 2020 Researchers at St. Jude Children’s Research Hospital have identified the mechanisms behind inflammasome activation driven by infection with the fungal pathogen Aspergillus fumigatus. Fungal infection, especially with A. fumigatus, is a leading cause of infection-associated deaths in people with compromised immune systems. The work provides clues to a potential therapeutic approach for treating infectious and …
Alembic Pharma gets USFDA endorsement for Metolazone tablets Kumar Jeetendra | December 3, 2020 New Delhi, Dec 3 (PTI) Drug firm Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator for Metolazone tablets, indicated for the treatment of salt and water retention caused by heart failure or kidney disease. The approved product is therapeutically equivalent to the reference listed drug product Zaroxolyn Tablets 2.5 …
Rhizen Pharma gets USFDA endorsement for stage one clinical preliminaries for Covid-19 drug Kumar Jeetendra | December 3, 2020 New Delhi, Dec 2 (PTI) Rhizen Pharmaceuticals, a member firm of Alembic Pharmaceuticals, on Wednesday said it has received approval from the US health regulator to commence phase one clinical trials on retroviral oral drug for the treatment of COVID-19. The Switzerland-based firm, which will be a clinical-stage oncology-focussed biopharmaceutical company, has obtained approval for …
Smart Evaporator Assists Medicinal Chemistry Kumar Jeetendra | December 3, 2020 BioChromato Inc. has published an interview with the Department of Medicinal Chemistry and Molecular Pharmacology at Purdue University (Indiana, USA) that explains how the Smart Evaporator C1 has assisted them in isolating and purifying novel compounds from DMSO solutions for potential pharmaceutical use. Because the US Federal Drug Administration (FDA) does not approve DMSO formulations …
Efficient Scale-Up of Novel Agrochemicals Kumar Jeetendra | December 4, 2020 Asynt reports how Globachem Discovery (Alderley Park, UK) has benefited from the investment in ReactoMate reactor systems for the scale-up of novel agrochemicals. Globachem Discovery ( https://www.globachem.com/en/globachem-discovery# ) is the UK R&D arm of Globachem, a Belgian agrochemical business. The company operates in the early phases of the R&D pipeline, developing new molecules and chemistries …
FUJIFILM Irvine Scientific dispatches Sterile Express Media Service Kumar Jeetendra | December 4, 2020 FUJIFILM Irvine Scientific, Inc., today announced the launch of Sterile Express Media Service (SEMS), for small, rapid creation of non-GMP media tested for sterility. With SEMS, clients can request up to 100L of media, to be quickly manufactured in a Grade A/ISO 5 sterile environment, and have it shipped within 15 business days pending sterility …
ATCC presents new product with launch of SARS-CoV-2 external control unit Kumar Jeetendra | December 4, 2020 The ready-to-run kit provides controls in the rapidly changing COVID-19 testing landscape as a workflow-optimized kit with complete genome coverage that is widely compatible with most commercial and laboratory-developed tests. Federal regulation requires that clinical laboratories assess the performance of their testing applications. This new ATCC kit is a practical, kitted solution clinical laboratories can …
DT-109 Significantly Prevents Progression of Diet-Induced Non-Alcoholic Fatty Liver Disease Kumar Jeetendra | December 4, 2020 Ann Arbor, MI – December 4, 2020 – Life Science Newswire – Rom et al report today that the oral administration of the simple tri-peptide, DT-109 (Patent US8664177B2), prevents both development of non-alcoholic fatty liver disease (NAFLD) and late stage fibrosis in a murine model of diet-induced non-alcoholic steatohepatitis (NASH). The study titled, “Glycine-based treatment …
Fermenta Biotech USA, LLC acquires 52% interest in AGD Nutrition LLC Kumar Jeetendra | December 5, 2020 Fermenta Biotech Limited (FBL), India has announced that its wholly owned subsidiary Fermenta Biotech USA LLC (FBU), Wilmington, DE, has acquired a 52% stake in a US-based vitamin company, AGD Nutrition LLC (AGD), headquartered in Nacogdoches, Texas. The deal would combine the expertise of both companies and result in synergies that will bring in greater …
Adar Poonawalla Of Serum Institute Among 6 Named ‘Asians Of The Year’ :Singapore Daily Kumar Jeetendra | December 5, 2020 Adar Adar Poonawalla, the chief executive of the world’s largest vaccine Maker Serum Institute of India, is among six people named”Asians of the Year” by Singapore’s leading daily, The Straits Times for their work in fighting the COVID-19 pandemic. Pune-based Serum Institute of India (SII) has collaborated with the University of Oxford and the British-Swedish …
